SCHEMBL26260002

SCHEMBL26260002

COc1ccc2c(-c3ccoc3)c(OC)cc(-c3ccoc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.44
▸ PLG P00747 1/20 0.44
▸ PLAU P00749 1/20 0.44
▸ PLAT P00750 1/20 0.44
▸ KLK1 P06870 1/20 0.44
▸ PRSS1 P07477 1/20 0.44
▸ CYP3A4 P08684 8/20 0.42
▸ CYP1A2 P05177 7/20 0.42
▸ CYP2D6 P10635 7/20 0.42
▸ CYP2C19 P33261 7/20 0.42
▸ TSHR P16473 6/20 0.42
▸ USP2 O75604 5/20 0.42
▸ CLK4 Q9HAZ1 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HSD17B10 Q99714 4/20 0.39
▸ CYP2C9 P11712 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ GLA P06280 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260067 0.78 F2 (0.58) F2PLGPLAUPLATKLK1
SCHEMBL2753374 0.77 ALDH1A1 (0.48) F2PLGPLAUPLATKLK1
SCHEMBL2752947 0.77 CYP1A2 (0.59) CYP3A4CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL26259484 0.77 KDM4E (0.51) CYP3A4CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL26259504 0.74 MAPK13 (0.46) CYP3A4CYP1A2CYP2C19ALDH1A1HSD17B10
SCHEMBL10035040 0.74 PPARG (0.48) CYP3A4CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL26260037 0.73 CYP11B1 (0.53) CYP3A4CYP1A2CYP2D6CYP2C19CLK4
SCHEMBL26260045 0.73 MAOB (0.46) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL26260006 0.72 KMT2A (0.37) CYP3A4CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL9139295 0.70 TLR8 (0.59) CYP3A4CYP1A2CYP2D6CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 F2 1107/4885PLG 2388/4885PLAU 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback